The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Octapharma USA announced the FDA Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [...
read more
BioMarin Pharmaceutical Inc. announced that the European Commission (EC) granted marketing authorization for VOXZOGO® (vosoritide), a once daily ...
read more
Navega Therapeutics is developing a different approach with DNA targeting to treat chronic pain and aid in the opioid epidemic via epigenetic ...
read more
Abveris, Inc. ("Abveris") and Abilita Bio, Inc. ("Abilita"), both privately held biotechnology companies, announce a joint research collaboration that...
read more
Regeneron Pharmaceuticals Inc. announced that the United Kingdom's (UK) Medicines and Healthcare products Regulatory Agency (MHRA) has granted ...
read more
Wednesday, August 18, 2021
Harrow Health Inc, an ophthalmic healthcare company, entered into an agreement with Wakamoto Pharmaceutical Co., Ltd. to acquire the US and Canadian ...
read more
The U.S. FDA has approved an expanded label for Eli Lilly and Company's (NYSE: LLY) rapid-acting insulin, Lyumjev® (insulin lispro-aabc injection) 100...
read more
Mustang Bio Inc., a clinical-stage biopharmaceutical company focused on translating medical breakthroughs in cell and gene therapies into potential ...
read more
MindMed, a biotech company developing psychedelic-inspired therapies, announced the addition of Robert H. Dworkin, Ph.D. to its Scientific Advisory ...
read more
GoodRx Inc., America’s leading resource for healthcare savings, and Boehringer Ingelheim, a privately owned, leading global biopharmaceutical company,...
read more
Thursday, August 05, 2021
Bayer AG announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company utilizing novel discovery ...
read more
Wednesday, August 04, 2021
BioDelivery Sciences International Inc., a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic ...
read more
MindMed, a biotech company developing psychedelic-inspired therapies, announced that it will participate in and financially support the Digital ...
read more
The incidence of very rare thromboembolic events was far lower than in people diagnosed with COVID-19 infection. In a large real-world study, data ...
read more
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ...
read more